Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAutins Group Regulatory News (AUTG)

Share Price Information for Autins Group (AUTG)

Share Price is delayed by 15 minutes
Get Live Data
12.50    0.00 (0.00%)
Bid:
11.00
Ask:
14.00
Spread: 3.00 (27.273%)
Market Cap: £6.83m
AUTG Live PriceLast checked at - London Stock Exchange

Intraday Autins Group Share Chart

Board Changes

19 Nov 2025 12:00

RNS Number : 1829I
Autins Group PLC
19 November 2025
 

19 November 2025

 

Autins Group plc

(the "Company" or the "Group")

 

Board Changes

 

Autins Group plc (AIM: AUTG), the UK and European based manufacturer of the patented Neptune melt-blown material and specialist in the design, manufacture, and supply of acoustic and thermal insulation solutions, announces the appointment of Trevor Brown as a Non-Executive Director of the Company, and resignation of Dr Qu Li as Non-Executive Director, with immediate effect.

 

Trevor Brown is a director and representative of Truetide PLC ("Truetide"), previously Braveheart Investment Group PLC, which holds 29.09% of the Company's issued share capital. In conjunction with Trevor Brown's appointment, Dr Qu Li (also a director and representative of Truetide) will be stepping down as Non-Executive Director of the Company. The Company, Truetide and the Company's nominated adviser have a Relationship Agreement in place to ensure the Company is capable of carrying on its business independently at all times.

 

Trevor Brown is currently Chief Executive Officer of Truetide PLC, trading on AIM, having joined the company as a non-executive director in 2014. Trevor has acted as a Chief Executive Officer, executive director and non-executive director for a wide range of both listed and private companies in a range of sectors over 40 years. Trevor is also Chief Executive Officer of Imaging Biometrics Limited, which is listed on the Main Market of the London Stock Exchange.

 

The Board would like to thank Dr Qu Li for her contribution to the Company during her tenure and wishes her well for the future.

 

Regulatory disclosures

 

In accordance with Schedule 2(g) of the AIM Rules for Companies, Trevor Edward Brown (aged 79) is, or has been within the previous five years, a director or partner of the following companies or partnerships:

 

Current directorships/partnerships

Past directorships/partnerships

· Braveheart Academic Seed Funding GP Ltd

· Chamberlin plc

· Free Publishing Ltd

· Imaging Biometrics Ltd 

· Kirkstall Ltd

· Paraytec Ltd

· Ridings Holdings Ltd

· Stone Checker Software Ltd

· Truetide Ltd (formerly Braveheart Investment Group Ltd)

· Truetide PLC (formerly Braveheart Investment Group PLC)

· The Ridings Early Growth Investment Company Ltd

· Combrook Holding Ltd

· Free Association Books Ltd

· Nanosynth Group Plc

 

 

On 8 August 2025, Chamberlin plc, a company of which Trevor Brown is a director, was placed into liquidation, following the appointment of administrators to its two trading subsidiaries on 20 May 2024. As at the date of this announcement, the company remains in compulsory liquidation.

 

There is no further information to be disclosed pursuant to Schedule 2(g) of the AIM Rules for Companies.

 

 

For further information please contact:

Autins Group plc

Andy Bloomer, Chief Executive

Adam Attwood, Chairman

 

 

Via Singer Capital Markets

Singer Capital Markets

(Nominated Adviser and Broker)

Asha Chotai

James Todd

 

Tel: 020 7496 3000

 

About Autins

 

Autins is a UK and continental Europe based industrial materials technology business that specialises in the design, manufacture, and supply of acoustic and thermal products. Its key markets are automotive, flooring, office furniture and commercial vehicles where it supplies products and services to more than 160 customer locations across Europe.

 

Autins is the UK and European manufacturer of the proprietary Neptune melt-blown material and specialises in the design, manufacture, and supply of acoustic and thermal insulation solutions.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEANFNFDPSFEA
Date   Source Headline
12th May 20267:00 amRNSLoan Repayment and New Facility
5th May 20267:00 amRNSYear-end Trading & Business Update
1st Dec 20257:00 amRNS-RAppointment to SMMT Executive Board
25th Nov 20257:00 amRNSInterim Results
19th Nov 202512:00 pmRNSBoard Changes
17th Sep 20251:47 pmRNSResult of Annual General Meeting
17th Sep 20257:00 amRNSAGM Trading Update
8th Aug 20251:00 pmRNSNotice of AGM
24th Jun 202511:24 amRNSInvestor Presentation via Investor Meet Company
24th Jun 20257:00 amRNSFinal Results
29th Apr 20257:00 amRNSTrading Update
3rd Mar 20257:00 amRNSAppointment of Chief Financial Officer
10th Dec 20241:28 pmRNSDirector/PDMR Shareholding
2nd Dec 20244:22 pmRNSHolding(s) in Company
27th Nov 20247:00 amRNSInterim Results
18th Nov 20247:00 amRNSBoard Change
26th Sep 20249:30 amRNSAppointment of Non-Executive Director
27th Jun 20247:00 amRNSInterim Results
26th Jun 20242:03 pmRNSAcquisition of further interest in Autins Group
4th Jun 202412:51 pmRNSStandard form for notification of major holdings
29th Apr 20242:07 pmRNSHolding(s) in Company
10th Apr 20247:00 amRNSHolding(s) in Company
28th Mar 20242:52 pmRNSResult of AGM
6th Mar 20244:46 pmRNSHolding(s) in Company
6th Mar 20244:40 pmRNSHolding(s) in Company
4th Mar 20247:03 amRNSNotice of AGM
4th Mar 20247:02 amRNSFull Year Results
4th Mar 20247:00 amRNSAppointment of Chief Executive Officer
13th Nov 20237:00 amRNSAppointment of Non-Executive Director
20th Oct 20237:00 amRNSFull-Year Trading Update
27th Jun 20237:00 amRNSInterim Results
15th May 20237:00 amRNSAppointment of Non-Executive Director
11th Apr 202310:20 amRNSHolding(s) in Company
28th Mar 20232:12 pmRNSResult of Annual General Meeting
22nd Feb 20237:00 amRNSPublication of Report & Accounts and Notice of AGM
31st Jan 20237:00 amRNSFull Year Results
17th Jan 20237:00 amRNSHolding(s) in Company
13th Dec 20224:37 pmRNSHolding(s) in Company
21st Oct 202210:33 amRNSHolding(s) in Company
10th Oct 20227:00 amRNSTrading Update
28th Jun 20227:00 amRNSInterim Results
9th Jun 20227:00 amRNSChange of Auditor
17th Mar 20223:44 pmRNSResult of AGM
17th Mar 20227:00 amRNSAGM Statement
21st Feb 20225:45 pmRNSNotice of AGM
28th Jan 20221:55 pmRNSHolding(s) in Company
25th Jan 20227:00 amRNSFull Year Results
9th Dec 20212:27 pmRNSResult of General Meeting
19th Nov 20215:47 pmRNSClose of Bookbuild and Result of Placing
19th Nov 20213:33 pmRNSProposed Placing to raise £3.0m & Notice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.